Why is the #Polypill a “Secret Medicine” and not available on the NHS? This article in the British Journal of General Practice @BJGPjournal discusses some of the reasons: https://t.co/doN4LG4ZUY
“To be successful, preventive interventions need to reach all who stand to benefit.” say Professors Wald and Hingorani in their letter that references the #polypill in @guardianletters : https://t.co/VXiywm3AFz
A large scale randomised controlled study provides further evidence for the effectiveness and safety of the #polypill for primary and secondary #CVD prevention. https://t.co/V2aNOoz2Sb
A study shows that #Polypill has the potential of preventing many more #heart attacks and #strokes than the NHS Health Check Programme. https://t.co/CkH7QL9aeL
"Statins, more than any other drugs in the 21st century, have completely changed the ability to prevent cardiovascular disease events" #polypill
https://t.co/WY5TeoCEvA
A study on 155,000 people published online in the Lancet on August 29, 2022 shows that muscle aches and weakness due to statins are rare, effecting about 1% who start taking a statin.
https://t.co/OGOCOZmAfN
Another trial published online in the New England Journal of Medicine shows the benefit of a Polypill in cardiovascular disease prevention with a supportive editorial.
https://t.co/52TqCG98dE
Further endorsement of the #polypill in the primary prevention of cardiovascular disease published in the Lancet in August 2021:
https://t.co/geZXDPIlW1
An extra benefit from the #Polypill Prevention Programme is the prevention of #headaches including #migraine. A survey of Polypill participants showed that the Polypill prevents headaches in about one third of people who suffer from headaches. See https://t.co/JifVD2Q9W3
A new #polypill formulation is now available. The medication used in the Polypill Prevention Programme can now be prescribed in a single capsule, if following an on-line medical assessment, a person is judged suitable for the preventive medication. See https://t.co/9019NCKPu6
US study confirms beneficial effect of statin use on people aged 75 and older. This supports lifetime use of #polypill in reducing death from cardiovascular disease : https://t.co/pgAwzzrt54
Oxford researchers show reduced admission to hospitals among people with heart attacks emphasising the importance of primary prevention. This highlights the benefit of #Polypill.
https://t.co/iXqwt4BX3z